TCL Archive Researchers Feel Impact of Shutdown As Grant Review Stops, Funding Runs Dry January 5, 1996
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive White House Backs Down FY 86 Cuts, Says Now They Will Be Limited To Trimming Indirect Costs January 10, 1986